Zosyn (piperacillin/tazobactam) reformulation: Expanded compatibility and coadministration with lactated Ringer's solutions and selected aminoglycosides

scientific article published on April 2008

Zosyn (piperacillin/tazobactam) reformulation: Expanded compatibility and coadministration with lactated Ringer's solutions and selected aminoglycosides is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.2147/TCRM.S2564
P932PMC publication ID2504059
P698PubMed publication ID18728835

P2093author name stringJonathan Cohen
Syed M Shah
Hema R Dalal
Matthew McLaughlin
Narendra R Desai
P2860cites workMultivariate analysis of nuclear magnetic resonance data--characterization of critical drug substance quality of gentamicin sulfateQ30998760
Structure-activity relationships among the aminoglycoside antibiotics: role of hydroxyl and amino groupsQ34661679
Particulate contamination in selected parenteral drugsQ36663279
Stability of gentamicin, tobramycin, and amikacin in combination with four beta-lactam antibioticsQ41963259
Particulate matter contamination of intravenous antibiotics aggravates loss of functional capillary density in postischemic striated muscleQ43890600
Inline fluid dynamics in piggyback and manifold drug delivery systemsQ46458366
Microparticulate-induced phlebitis. Its prevention by in-line filtrationQ69880623
Stability of piperacillin sodium-tazobactam sodium and ranitidine hydrochloride in 0.9% sodium chloride injection during simulated Y-site administrationQ72361288
Compatibility of piperacillin sodium plus tazobactam with selected drugs during simulated Y-site injectionQ72516519
Linking extractables and leachables in container/closure applicationsQ81337699
Zinc content of commercial diluents widely used in drug admixtures prepared for intravenous infusionQ95411349
P275copyright licenseCreative Commons Attribution-NonCommercial 3.0 UnportedQ18810331
P6216copyright statuscopyrightedQ50423863
P433issue2
P921main subjectpiperacillin/tazobactamQ7197337
P304page(s)303-314
P577publication date2008-04-01
P1433published inTherapeutics and Clinical Risk ManagementQ15766913
P1476titleZosyn (piperacillin/tazobactam) reformulation: Expanded compatibility and coadministration with lactated Ringer's solutions and selected aminoglycosides
P478volume4

Reverse relations

cites work (P2860)
Q38284458Consensus guidelines for the use of empiric and diagnostic-driven antifungal treatment strategies in haematological malignancy, 2014.
Q42099155Do formulation differences between the reference listed drug and generic piperacillin-tazobactam impact reconstitution?
Q39516974Pharmacokinetics-Pharmacodynamics of Tazobactam in Combination with Piperacillin in an In Vitro Infection Model
Q43603048Physical compatibility of vancomycin and piperacillin sodium-tazobactam at concentrations typically used during prolonged infusions
Q39212088Stability of aseptically prepared tazocin solutions in polyvinyl chloride bags
Q84657307Structural characterization of the tobramycin-piperacillin reaction product formed at pH 6.0.
Q43859114The interaction between piperacillin-tazobactam and Aspergillus galactomannan antigenemia assay: is the story over?
Q53187811Visual and absorbance analyses of admixtures containing vancomycin and piperacillin-tazobactam at commonly used concentrations.
Q42233062Y-site compatibility of vancomycin and piperacillin/tazobactam at commonly utilized pediatric concentrations

Search more.